Anne Bouvier
Anne Bouvier publishes mostly in Hematology, Genetics and Molecular Biology, on topics such as Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment and Chronic Myeloid Leukemia Treatments.
- World rank
- #1,484,371 of 7,710,434 ranked researchers
- Rank in France
- #66,683 of 324,115
- Works
- 48
- Citations
- 718
- Citations per work
- 15.0
What does Anne Bouvier research?
Anne Bouvier's work is mostly in Medicine (58%), Biochemistry, Genetics and Molecular Biology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2858.5%
- Medicine2858.5%
- Everything else1632.6%
- Life Sciences48.9%
- 1Hematology27% of their works
- 2Genetics18% of their works
- 3Molecular Biology9% of their works
- 4Rheumatology6% of their works
- 5Public Health, Environmental and Occupational Health4% of their works
- 6Pulmonary and Respiratory Medicine3% of their works
Research topics
- Acute Myeloid Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Myeloid Leukemia Treatments
- Acute Lymphoblastic Leukemia research
- Chronic Lymphocytic Leukemia Research
- Otitis Media and Relapsing Polychondritis
- Hematopoietic Stem Cell Transplantation
- Histone Deacetylase Inhibitors Research
Which keywords describe Anne Bouvier's research?
The keywords of their largest research topics: Prognostic Factors, Hematopoietic Stem Cells, Acute Myeloid Leukemia, AML, JAK2 Mutation, Myelofibrosis, BCR-ABL and Imatinib.
- Histone Deacetylases
- Graft-versus-Host Disease
- VEXAS Syndrome
- Genomic Aberrations
- Childhood Cancer
- Imatinib
- Myelofibrosis
- Acute Myeloid Leukemia
- Hematopoietic Stem Cells
- Prognostic Factors
- AML
- JAK2 Mutation
- BCR-ABL
- Acute Lymphoblastic Leukemia
- Chronic Lymphocytic Leukemia
- Relapsing Polychondritis
- Bone Marrow Niche
- HDAC Inhibitors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Prognostic Factors323 topics
- Hematopoietic Stem Cells252 topics
- AML211 topic
- Acute Myeloid Leukemia211 topic
- JAK2 Mutation141 topic
- Myelofibrosis141 topic
- BCR-ABL81 topic
- Imatinib81 topic
- Acute Lymphoblastic Leukemia61 topic
- Childhood Cancer61 topic
- Chronic Lymphocytic Leukemia51 topic
- Genomic Aberrations51 topic
- Relapsing Polychondritis51 topic
- VEXAS Syndrome51 topic
- Bone Marrow Niche41 topic
- Graft-versus-Host Disease41 topic
- HDAC Inhibitors31 topic
- Histone Deacetylases31 topic
Where does Anne Bouvier work?
Anne Bouvier's main affiliation in the publication record is Université d'Angers, France.
How many publications and citations does Anne Bouvier have?
OpenAlex counts 48 works and 718 citations for Anne Bouvier, an h-index of 13, ranking #1,484,371 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Anne Bouvier. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.